USE OF TNF INHIBITORS IS ASSOCIATED WITH A REDUCED RISK OF DIABETES IN RA PATIENTS

被引：0
|
作者：
Lillegraven, S. [1 ]
Greenberg, J. D. [2 ]
Reed, G. W. [3 ]
Saunders, K. [4 ]
Curtis, J. R. [5 ]
Harrold, L. [6 ]
Hochberg, M. C. [7 ]
Pappas, D. [8 ]
Kremer, J. M. [9 ,10 ]
Solomon, D. H. [11 ]
机构：
[1] Diakonhjemmet Hosp, Oslo, Norway
[2] NYU Hosp Joint Dis, New York, NY USA
[3] Corrona Inc, Worcester, MA USA
[4] Corrona Inc, Southborough, MA USA
[5] Univ Alabama Birmingham, Birmingham, AL USA
[6] UMass Med Sch, Worcester, MA USA
[7] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[8] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
[9] Albany Med Coll, Albany, NY 12208 USA
[10] Ctr Rheumatol, Albany, NY USA
[11] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：106 / 107
页数：2
相关论文
共 50 条
  • [11] RHEUMATOID ARTHRITIS TNF inhibitors and cardiovascular risk management in RA
    Pope, Janet E.
    NATURE REVIEWS RHEUMATOLOGY, 2016, 12 (06) : 317 - U17
  • [12] In RA, new use of JAK inhibitors was associated with nonmelanoma skin cancer vs. TNF inhibitors at 2 y
    Schattner, Ami
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (07) : JC83 - JC83
  • [13] Tocilizumab or TNF inhibitors in RA?
    Leake I.
    Nature Reviews Rheumatology, 2018, 14 (7) : 384 - 384
  • [14] Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
    Lalau, Jean-Daniel
    Al-Salameh, Abdallah
    Hadjadj, Samy
    Goronflot, Thomas
    Wiernsperger, Nicolas
    Pichelin, Matthieu
    Allix, Ingrid
    Amadou, Coralie
    Bourron, Olivier
    Duriez, Thierry
    Gautier, Jean-Francois
    Dutour, Anne
    Gonfroy, Celine
    Gouet, Didier
    Joubert, Michael
    Julier, Ingrid
    Larger, Etienne
    Marchand, Lucien
    Marre, Michel
    Meyer, Laurent
    Olivier, Frederique
    Prevost, Gaetan
    Quiniou, Pascale
    Raffaitin-Cardin, Christelle
    Roussel, Ronan
    Saulnier, Pierre-Jean
    Seret-Begue, Dominique
    Thivolet, Charles
    Vatier, Camille
    Desailloud, Rachel
    Wargny, Matthieu
    Gourdy, Pierre
    Cariou, Bertrand
    DIABETES & METABOLISM, 2021, 47 (05)
  • [15] Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?
    Nocturne, Gaetane
    Seror, Raphaele
    Mariette, Xavier
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (02)
  • [16] METFORMIN USE IS NOT ASSOCIATED WITH A REDUCED RISK OF DEMENTIA IN OLDER VETERANS WITH DIABETES
    Orkaby, A. R.
    Cho, K.
    Cormack, J. B.
    Gagnon, D. R.
    Driver, J.
    GERONTOLOGIST, 2016, 56 : 62 - 62
  • [17] Association of methotrexate(MTX), TNF-inhibitors (TNF-1) and prednisone (PRED) with risk of infection among RA patients
    Greenberg, J. D.
    Kavanaugh, A.
    Hochberg, M.
    Kremer, J. M.
    Reed, G.
    Zheng, C.
    Tindall, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 171 - 171
  • [18] Use of fluorquinolones is associated with a reduced risk of coronary heart disease in diabetes mellitus type 2 patients
    Erkens, JA
    Klungel, OH
    Herings, RMC
    Stolk, RP
    Spoelstra, JA
    Grobbee, DE
    Leufkens, HGM
    EUROPEAN HEART JOURNAL, 2002, 23 (20) : 1575 - 1579
  • [19] Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
    Campbell, Jared M.
    Stephenson, Matthew D.
    de Courten, Barbora
    Chapman, Ian
    Bellman, Susan M.
    Aromataris, Edoardo
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 65 (04) : 1225 - 1236
  • [20] Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus
    Chin-Hsiao Tseng
    Scientific Reports, 11
12345